Shahin Zandieh | Medicine | Innovative Research Award

Prof. Dr. Shahin Zandieh | Medicine | Innovative Research Award

Professor | Hanusch-Krankenhaus | Austria

Prof. Dr. Shahin Zandieh is a medical imaging and diagnostic radiology specialist whose research spans musculoskeletal biomechanics, cardiovascular imaging, oncologic radiology, and advanced radiomics. With 49 publications, over 550 citations, and an h-index of 12, his scientific work reflects a strong interdisciplinary approach to clinical diagnosis, disease characterization, and imaging-guided evaluation of structural abnormalities. His contributions extend across orthopedic, cardiovascular, endocrine, and oncological systems through innovative use of MRI, CT, X-ray, and radiomic feature extraction.A notable component of Prof. Dr. Zandieh’s research focuses on orthopedic imaging and biomechanical assessment, including comparative studies such as the analysis of proximal chevron osteotomy versus Lapidus arthrodesis in managing hallux valgus deformities. His work provides clinically meaningful insights for surgeons, improving treatment selection, operative planning, and postoperative evaluation.In the field of cardiovascular imaging, he has explored rare cardiac pathologies such as “toothpaste tumor” manifestations of the mitral valve, enhancing the diagnostic awareness of uncommon presentations through multimodal radiologic evaluation. His studies also extend to endocrine-related morphologic changes, such as MRI-based radiomics used to detect cardiac variations influenced by autoimmune thyroid disorders—paving the way for AI-assisted diagnostic tools.Prof. Dr. Zandieh has also contributed to oncologic radiology, documenting rare metastatic patterns including giant ovarian metastasis from breast cancer. These case-based investigations broaden clinician understanding of atypical disease progression.Collectively, his research strengthens clinical imaging practice by integrating radiomics, rare-case documentation, biomechanics, and cross-system diagnostic strategies—advancing precision diagnosis, personalized treatment planning, and the broader field of radiological science.

Profiles: Scopus |ResearchGate

Featured Publications

Fezoulidis, N., Slavicek, J., Nonninger, J.-N., … , & Zandieh, S. (2025). Quantitative CT perfusion and radiomics reveal complementary markers of treatment response in HCC patients undergoing TACE.

Behanova, M., Sokhan, A., Haschka, J., … , & Kocijan, R. (2025). AI-supported opportunistic detection of vertebral fractures on routine CT scans: Diagnostic performance and clinical relevance.

Al-Taiee, B., Lamiss, M., Slavicek, J., … , & Zandieh, S. (2025). Disseminated miliary tuberculosis following intravesical BCG therapy: A rare but serious complication.

Kainz, B., Hergan, K., & Zandieh, S. (2025). Große Ovarialmetastase beim Mammakarzinom: Ein seltener Fall.

Prof. Dr. Shahin Zandieh’s work advances medical imaging by integrating radiomics, AI-supported diagnostics, and multimodal radiology to improve early disease detection, treatment response evaluation, and clinical decision-making. His contributions enhance patient safety, elevate diagnostic precision across oncology, cardiology, musculoskeletal, and infectious diseases, and support global healthcare innovation by translating advanced imaging technologies into practical, life-saving clinical applications.

Manouchehr Ashrafpour | Medicine | Best Scholar Award

Dr. Manouchehr Ashrafpour | Medicine | Best Scholar Award

Faculty Member | Babol University of Medical Sciences | Iran

Dr. Manouchehr Ashrafpour is a prominent neuroscientist and biomedical researcher at Babol University of Medical Sciences, renowned for his extensive contributions to neuropharmacology, molecular neuroscience, and neurodegenerative disease research. He earned his advanced degrees in medical sciences and neuroscience, building a strong academic foundation that bridges cellular biology and clinical neurotherapeutics. Throughout his professional career, Dr. Ashrafpour has demonstrated exceptional expertise in experimental neurobiology, drug delivery systems, and the molecular mechanisms underlying brain disorders such as Alzheimer’s disease, Parkinson’s disease, epilepsy, and multiple sclerosis. His research primarily focuses on the neuroprotective effects of natural bioactive compounds and nanotechnology-based formulations, including curcumin-, piperine-, arbutin-, and quercetin-loaded nanoparticles, which have shown promising results in reducing oxidative stress, glial activation, and neuronal degeneration. He possesses advanced research skills in animal modeling, histopathological assessment, biochemical analysis, neurobehavioral testing, and nanomedicine formulation, complemented by a strong command of cellular electrophysiology and molecular signaling studies. His professional experience encompasses collaborations with leading neuroscientists on projects exploring the role of vitamins, antioxidants, and receptor modulation (notably adenosine A2A receptor blockade) in promoting neural repair and functional recovery. Dr. Ashrafpour’s scholarly achievements are reflected in his strong Scopus record, which includes over 700 citations, numerous peer-reviewed documents, and an h-index of 17, underscoring his global academic influence. He has received recognition and academic honors for his innovative work in neurotherapeutic discovery and translational neuroscience, highlighting his commitment to improving treatment strategies for neurodegenerative diseases. In conclusion, Dr. Manouchehr Ashrafpour stands as a distinguished figure in contemporary neuroscience, whose multidisciplinary approach—spanning nanotechnology, pharmacology, and neurobiology—continues to shape the future of neuroprotective medicine and inspire emerging researchers in biomedical sciences worldwide.

Profiles: ORCID | Google Scholar 

Featured Publications

  1. Naeimi, R., Safarpour, F., Hashemian, M., Tashakorian, H., Ahmadian, S. R., & Ashrafpour, M. (2018). Curcumin-loaded nanoparticles ameliorate glial activation and improve myelin repair in lyolecithin-induced focal demyelination model of rat corpus callosum. Neuroscience Letters, 674, 1–10. Cited by 71.

  2. Mansoor, S. R., Hashemian, M., Khalili-Fomeshi, M., Ashrafpour, M., & Moghadamnia, A. A. (2018). Upregulation of klotho and erythropoietin contributes to the neuroprotection induced by curcumin-loaded nanoparticles in an experimental model of chronic epilepsy. Brain Research Bulletin, 142, 281–288. Cited by 52.

  3. Khalili-Fomeshi, M., Azizi, M. G., Esmaeili, M. R., Gol, M., Kazemi, S., & Ashrafpour, M. (2018). Piperine restores streptozotocin-induced cognitive impairments: Insights into oxidative balance in cerebrospinal fluid and hippocampus. Behavioural Brain Research, 337, 131–138. Cited by 49.

  4. Dastan, Z., Pouramir, M., Ghasemi-Kasman, M., Ghasemzadeh, Z., Dadgar, M., & Ashrafpour, M. (2019). Arbutin reduces cognitive deficit and oxidative stress in an animal model of Alzheimer’s disease. International Journal of Neuroscience, 129(11), 1145–1153. Cited by 45.

  5. Dadgar, M., Pouramir, M., Dastan, Z., Ghasemi-Kasman, M., & Ashrafpour, M. (2018). Arbutin attenuates behavioral impairment and oxidative stress in an animal model of Parkinson’s disease. Avicenna Journal of Phytomedicine, 8(6), 533–540. Cited by 43.